Webinars
Comprehensive Global Testing Solutions for HCV Novel Therapeutics in Clinical Development
Christos Petropoulos, Ph.D., Chief Scientific Officer, Monogram Biosciences, a LabCorp Company
Learn More +
Clinical considerations for Alzheimer's biomarker assays
Paul Rhyne, Ph.D., Senior Technical Director of Biotechnology, Tandem Labs
Learn More +
Targeted Bioanalytical Proteomics by LC-MS/MS.
Bob Xiong, Ph.D., Associate Lab Director, Tandem Labs
Learn More +
Companion Diagnostics (CDx): Accelerating the path to commercialization
Alan Wookey, Executive Director of Companion Diagnostics
Learn More +
Circulating Tumor Cells (CTC) as a Biomarker Approach in Oncology
Dr. Ken Pennline, Vice President and Global Head of Cytometry Services
Learn More +
Podcasts
LabCorp Biorepository earns CAP accreditation
In this podcast, you'll learn more about the recent CAP accreditation of the LabCorp Biorespository and why this is significant - from Hannah Maynor, who is the Associate Director of this purpose-built facility. Hannah also talks about the strategic location and extensive capabilities of the Biorespository, as well as unique services that distinguish LabCorp from others.
Download Podcast +
Behind the scenes preview of AAPS annual meeting and exposition
In this podcast, you'll get a sneak peek behind the scenes at the upcoming AAPS meeting and exposition - from Todd Grosshandler, who is director of Sales at Tandem Labs. Todd talks about why AAPS is so important in our industry, and the activities that Tandem will be involved in at the conference in Chicago. You'll also hear about the promotions at our exhibit booth, as well as some of the recent news and service capabilities Tandem will be discussing with clients.
Download Podcast +
Biomarker-Focused Strategies for Personalized Medicine
Biomarkers may soon play a more prominent role in the field of personalized medicine. In this podcast, Ken Pennline, PhD, Vice President and Global Head of Cytometry Services at LabCorp Clinical Trials, discusses how identifying unique biomarkers in drug discovery can help pharmaceutical companies to validate, implement and develop more personalized medicine tests.
Download Podcast +
Non-proprietary assays (NPA): The bioanalytical solution for generics, drug-drug interaction, and new formulation projects
In this podcast, you’ll hear Spencer Carter, PhD, Associate Laboratory Director of the Tandem Labs facility in Salt Lake City, Utah. Dr. Carter oversees the development of non-proprietary assays and will explain the many advantages Tandem Labs can provide to clients in this area.
Download Podcast +
Scientific Posters
Analysis of gene expression profiling of formalin-fixed and paraffin-embedded tumor tissues from preclinical models and patient samples in early phase clinical trials
by Sirinivas Chunduru1, Jim Yan2, Eric Neiman1, Jennifer Burns1, David Weng1; Presented at Biomarkers and Diagnostics World Congress; May 6-8, 2013; Philadelphia, PA.
1TetraLogic Pharmaceuticals, 343 Phoenixville Pike, Malvern, PA 19355; 2LabCorp Clinical Trials,
4307 Emperor Blvd, Durham, NC 27703
Download Poster +